Global Preclinical Oncology CRO Market Growth (Status and Outlook) 2025-2031

September 2025 | 110 pages | ID: G10A1285385AEN
LP Information

Abstracts

According to this study, the global Preclinical Oncology CRO market size will reach US$ 1086 million by 2031.

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.

The industry's leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.

LPI (LP Information)' newest research report, the “Preclinical Oncology CRO Industry Forecast” looks at past sales and reviews total world Preclinical Oncology CRO sales in 2024, providing a comprehensive analysis by region and market sector of projected Preclinical Oncology CRO sales for 2025 through 2031. With Preclinical Oncology CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preclinical Oncology CRO industry.

This Insight Report provides a comprehensive analysis of the global Preclinical Oncology CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preclinical Oncology CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preclinical Oncology CRO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preclinical Oncology CRO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preclinical Oncology CRO.

This report presents a comprehensive overview, market shares, and growth opportunities of Preclinical Oncology CRO market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Blood Cancer
• Solid Tumors
• Other

Segmentation by Application:

• In Vitro
• In Vivo

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Crown Bioscience
• Charles River Laboratory
• ICON Plc.
• Eurofins Scientific
• Taconic Biosciences
• Covance
• EVOTEC
• The Jackson Laboratory
• Wuxi AppTec.
• MI Bioresearch, Inc.
• Champion Oncology, Inc.
• Xentech

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Preclinical Oncology CRO Market Size (2020-2031)
  2.1.2 Preclinical Oncology CRO Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Preclinical Oncology CRO by Country/Region (2020, 2024 & 2031)
2.2 Preclinical Oncology CRO Segment by Type
  2.2.1 Blood Cancer
  2.2.2 Solid Tumors
  2.2.3 Other
2.3 Preclinical Oncology CRO Market Size by Type
  2.3.1 Preclinical Oncology CRO Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Preclinical Oncology CRO Market Size Market Share by Type (2020-2025)
2.4 Preclinical Oncology CRO Segment by Application
  2.4.1 In Vitro
  2.4.2 In Vivo
2.5 Preclinical Oncology CRO Market Size by Application
  2.5.1 Preclinical Oncology CRO Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Preclinical Oncology CRO Market Size Market Share by Application (2020-2025)

3 PRECLINICAL ONCOLOGY CRO MARKET SIZE BY PLAYER

3.1 Preclinical Oncology CRO Market Size Market Share by Player
  3.1.1 Global Preclinical Oncology CRO Revenue by Player (2020-2025)
  3.1.2 Global Preclinical Oncology CRO Revenue Market Share by Player (2020-2025)
3.2 Global Preclinical Oncology CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PRECLINICAL ONCOLOGY CRO BY REGION

4.1 Preclinical Oncology CRO Market Size by Region (2020-2025)
4.2 Global Preclinical Oncology CRO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Preclinical Oncology CRO Market Size Growth (2020-2025)
4.4 APAC Preclinical Oncology CRO Market Size Growth (2020-2025)
4.5 Europe Preclinical Oncology CRO Market Size Growth (2020-2025)
4.6 Middle East & Africa Preclinical Oncology CRO Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Preclinical Oncology CRO Market Size by Country (2020-2025)
5.2 Americas Preclinical Oncology CRO Market Size by Type (2020-2025)
5.3 Americas Preclinical Oncology CRO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Preclinical Oncology CRO Market Size by Region (2020-2025)
6.2 APAC Preclinical Oncology CRO Market Size by Type (2020-2025)
6.3 APAC Preclinical Oncology CRO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Preclinical Oncology CRO Market Size by Country (2020-2025)
7.2 Europe Preclinical Oncology CRO Market Size by Type (2020-2025)
7.3 Europe Preclinical Oncology CRO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Preclinical Oncology CRO by Region (2020-2025)
8.2 Middle East & Africa Preclinical Oncology CRO Market Size by Type (2020-2025)
8.3 Middle East & Africa Preclinical Oncology CRO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PRECLINICAL ONCOLOGY CRO MARKET FORECAST

10.1 Global Preclinical Oncology CRO Forecast by Region (2026-2031)
  10.1.1 Global Preclinical Oncology CRO Forecast by Region (2026-2031)
  10.1.2 Americas Preclinical Oncology CRO Forecast
  10.1.3 APAC Preclinical Oncology CRO Forecast
  10.1.4 Europe Preclinical Oncology CRO Forecast
  10.1.5 Middle East & Africa Preclinical Oncology CRO Forecast
10.2 Americas Preclinical Oncology CRO Forecast by Country (2026-2031)
  10.2.1 United States Market Preclinical Oncology CRO Forecast
  10.2.2 Canada Market Preclinical Oncology CRO Forecast
  10.2.3 Mexico Market Preclinical Oncology CRO Forecast
  10.2.4 Brazil Market Preclinical Oncology CRO Forecast
10.3 APAC Preclinical Oncology CRO Forecast by Region (2026-2031)
  10.3.1 China Preclinical Oncology CRO Market Forecast
  10.3.2 Japan Market Preclinical Oncology CRO Forecast
  10.3.3 Korea Market Preclinical Oncology CRO Forecast
  10.3.4 Southeast Asia Market Preclinical Oncology CRO Forecast
  10.3.5 India Market Preclinical Oncology CRO Forecast
  10.3.6 Australia Market Preclinical Oncology CRO Forecast
10.4 Europe Preclinical Oncology CRO Forecast by Country (2026-2031)
  10.4.1 Germany Market Preclinical Oncology CRO Forecast
  10.4.2 France Market Preclinical Oncology CRO Forecast
  10.4.3 UK Market Preclinical Oncology CRO Forecast
  10.4.4 Italy Market Preclinical Oncology CRO Forecast
  10.4.5 Russia Market Preclinical Oncology CRO Forecast
10.5 Middle East & Africa Preclinical Oncology CRO Forecast by Region (2026-2031)
  10.5.1 Egypt Market Preclinical Oncology CRO Forecast
  10.5.2 South Africa Market Preclinical Oncology CRO Forecast
  10.5.3 Israel Market Preclinical Oncology CRO Forecast
  10.5.4 Turkey Market Preclinical Oncology CRO Forecast
10.6 Global Preclinical Oncology CRO Forecast by Type (2026-2031)
10.7 Global Preclinical Oncology CRO Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Preclinical Oncology CRO Forecast

11 KEY PLAYERS ANALYSIS

11.1 Crown Bioscience
  11.1.1 Crown Bioscience Company Information
  11.1.2 Crown Bioscience Preclinical Oncology CRO Product Offered
  11.1.3 Crown Bioscience Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Crown Bioscience Main Business Overview
  11.1.5 Crown Bioscience Latest Developments
11.2 Charles River Laboratory
  11.2.1 Charles River Laboratory Company Information
  11.2.2 Charles River Laboratory Preclinical Oncology CRO Product Offered
  11.2.3 Charles River Laboratory Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Charles River Laboratory Main Business Overview
  11.2.5 Charles River Laboratory Latest Developments
11.3 ICON Plc.
  11.3.1 ICON Plc. Company Information
  11.3.2 ICON Plc. Preclinical Oncology CRO Product Offered
  11.3.3 ICON Plc. Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 ICON Plc. Main Business Overview
  11.3.5 ICON Plc. Latest Developments
11.4 Eurofins Scientific
  11.4.1 Eurofins Scientific Company Information
  11.4.2 Eurofins Scientific Preclinical Oncology CRO Product Offered
  11.4.3 Eurofins Scientific Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Eurofins Scientific Main Business Overview
  11.4.5 Eurofins Scientific Latest Developments
11.5 Taconic Biosciences
  11.5.1 Taconic Biosciences Company Information
  11.5.2 Taconic Biosciences Preclinical Oncology CRO Product Offered
  11.5.3 Taconic Biosciences Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Taconic Biosciences Main Business Overview
  11.5.5 Taconic Biosciences Latest Developments
11.6 Covance
  11.6.1 Covance Company Information
  11.6.2 Covance Preclinical Oncology CRO Product Offered
  11.6.3 Covance Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Covance Main Business Overview
  11.6.5 Covance Latest Developments
11.7 EVOTEC
  11.7.1 EVOTEC Company Information
  11.7.2 EVOTEC Preclinical Oncology CRO Product Offered
  11.7.3 EVOTEC Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 EVOTEC Main Business Overview
  11.7.5 EVOTEC Latest Developments
11.8 The Jackson Laboratory
  11.8.1 The Jackson Laboratory Company Information
  11.8.2 The Jackson Laboratory Preclinical Oncology CRO Product Offered
  11.8.3 The Jackson Laboratory Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 The Jackson Laboratory Main Business Overview
  11.8.5 The Jackson Laboratory Latest Developments
11.9 Wuxi AppTec.
  11.9.1 Wuxi AppTec. Company Information
  11.9.2 Wuxi AppTec. Preclinical Oncology CRO Product Offered
  11.9.3 Wuxi AppTec. Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Wuxi AppTec. Main Business Overview
  11.9.5 Wuxi AppTec. Latest Developments
11.10 MI Bioresearch, Inc.
  11.10.1 MI Bioresearch, Inc. Company Information
  11.10.2 MI Bioresearch, Inc. Preclinical Oncology CRO Product Offered
  11.10.3 MI Bioresearch, Inc. Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 MI Bioresearch, Inc. Main Business Overview
  11.10.5 MI Bioresearch, Inc. Latest Developments
11.11 Champion Oncology, Inc.
  11.11.1 Champion Oncology, Inc. Company Information
  11.11.2 Champion Oncology, Inc. Preclinical Oncology CRO Product Offered
  11.11.3 Champion Oncology, Inc. Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Champion Oncology, Inc. Main Business Overview
  11.11.5 Champion Oncology, Inc. Latest Developments
11.12 Xentech
  11.12.1 Xentech Company Information
  11.12.2 Xentech Preclinical Oncology CRO Product Offered
  11.12.3 Xentech Preclinical Oncology CRO Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Xentech Main Business Overview
  11.12.5 Xentech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Preclinical Oncology CRO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Preclinical Oncology CRO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Blood Cancer
Table 4. Major Players of Solid Tumors
Table 5. Major Players of Other
Table 6. Preclinical Oncology CRO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Preclinical Oncology CRO Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Preclinical Oncology CRO Market Size Market Share by Type (2020-2025)
Table 9. Preclinical Oncology CRO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Preclinical Oncology CRO Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Preclinical Oncology CRO Market Size Market Share by Application (2020-2025)
Table 12. Global Preclinical Oncology CRO Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Preclinical Oncology CRO Revenue Market Share by Player (2020-2025)
Table 14. Preclinical Oncology CRO Key Players Head office and Products Offered
Table 15. Preclinical Oncology CRO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Preclinical Oncology CRO Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Preclinical Oncology CRO Market Size Market Share by Region (2020-2025)
Table 20. Global Preclinical Oncology CRO Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Preclinical Oncology CRO Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Preclinical Oncology CRO Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Preclinical Oncology CRO Market Size Market Share by Country (2020-2025)
Table 24. Americas Preclinical Oncology CRO Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Preclinical Oncology CRO Market Size Market Share by Type (2020-2025)
Table 26. Americas Preclinical Oncology CRO Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Preclinical Oncology CRO Market Size Market Share by Application (2020-2025)
Table 28. APAC Preclinical Oncology CRO Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Preclinical Oncology CRO Market Size Market Share by Region (2020-2025)
Table 30. APAC Preclinical Oncology CRO Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Preclinical Oncology CRO Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Preclinical Oncology CRO Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Preclinical Oncology CRO Market Size Market Share by Country (2020-2025)
Table 34. Europe Preclinical Oncology CRO Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Preclinical Oncology CRO Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Preclinical Oncology CRO Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Preclinical Oncology CRO Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Preclinical Oncology CRO Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Preclinical Oncology CRO
Table 40. Key Market Challenges & Risks of Preclinical Oncology CRO
Table 41. Key Industry Trends of Preclinical Oncology CRO
Table 42. Global Preclinical Oncology CRO Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Preclinical Oncology CRO Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Preclinical Oncology CRO Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Preclinical Oncology CRO Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Crown Bioscience Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 47. Crown Bioscience Preclinical Oncology CRO Product Offered
Table 48. Crown Bioscience Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Crown Bioscience Main Business
Table 50. Crown Bioscience Latest Developments
Table 51. Charles River Laboratory Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 52. Charles River Laboratory Preclinical Oncology CRO Product Offered
Table 53. Charles River Laboratory Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Charles River Laboratory Main Business
Table 55. Charles River Laboratory Latest Developments
Table 56. ICON Plc. Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 57. ICON Plc. Preclinical Oncology CRO Product Offered
Table 58. ICON Plc. Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. ICON Plc. Main Business
Table 60. ICON Plc. Latest Developments
Table 61. Eurofins Scientific Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 62. Eurofins Scientific Preclinical Oncology CRO Product Offered
Table 63. Eurofins Scientific Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Eurofins Scientific Main Business
Table 65. Eurofins Scientific Latest Developments
Table 66. Taconic Biosciences Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 67. Taconic Biosciences Preclinical Oncology CRO Product Offered
Table 68. Taconic Biosciences Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Taconic Biosciences Main Business
Table 70. Taconic Biosciences Latest Developments
Table 71. Covance Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 72. Covance Preclinical Oncology CRO Product Offered
Table 73. Covance Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Covance Main Business
Table 75. Covance Latest Developments
Table 76. EVOTEC Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 77. EVOTEC Preclinical Oncology CRO Product Offered
Table 78. EVOTEC Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. EVOTEC Main Business
Table 80. EVOTEC Latest Developments
Table 81. The Jackson Laboratory Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 82. The Jackson Laboratory Preclinical Oncology CRO Product Offered
Table 83. The Jackson Laboratory Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. The Jackson Laboratory Main Business
Table 85. The Jackson Laboratory Latest Developments
Table 86. Wuxi AppTec. Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 87. Wuxi AppTec. Preclinical Oncology CRO Product Offered
Table 88. Wuxi AppTec. Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Wuxi AppTec. Main Business
Table 90. Wuxi AppTec. Latest Developments
Table 91. MI Bioresearch, Inc. Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 92. MI Bioresearch, Inc. Preclinical Oncology CRO Product Offered
Table 93. MI Bioresearch, Inc. Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. MI Bioresearch, Inc. Main Business
Table 95. MI Bioresearch, Inc. Latest Developments
Table 96. Champion Oncology, Inc. Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 97. Champion Oncology, Inc. Preclinical Oncology CRO Product Offered
Table 98. Champion Oncology, Inc. Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Champion Oncology, Inc. Main Business
Table 100. Champion Oncology, Inc. Latest Developments
Table 101. Xentech Details, Company Type, Preclinical Oncology CRO Area Served and Its Competitors
Table 102. Xentech Preclinical Oncology CRO Product Offered
Table 103. Xentech Preclinical Oncology CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Xentech Main Business
Table 105. Xentech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Preclinical Oncology CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Preclinical Oncology CRO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Preclinical Oncology CRO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Preclinical Oncology CRO Sales Market Share by Country/Region (2024)
Figure 8. Preclinical Oncology CRO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Preclinical Oncology CRO Market Size Market Share by Type in 2024
Figure 10. Preclinical Oncology CRO in In Vitro
Figure 11. Global Preclinical Oncology CRO Market: In Vitro (2020-2025) & ($ millions)
Figure 12. Preclinical Oncology CRO in In Vivo
Figure 13. Global Preclinical Oncology CRO Market: In Vivo (2020-2025) & ($ millions)
Figure 14. Global Preclinical Oncology CRO Market Size Market Share by Application in 2024
Figure 15. Global Preclinical Oncology CRO Revenue Market Share by Player in 2024
Figure 16. Global Preclinical Oncology CRO Market Size Market Share by Region (2020-2025)
Figure 17. Americas Preclinical Oncology CRO Market Size 2020-2025 ($ millions)
Figure 18. APAC Preclinical Oncology CRO Market Size 2020-2025 ($ millions)
Figure 19. Europe Preclinical Oncology CRO Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Preclinical Oncology CRO Market Size 2020-2025 ($ millions)
Figure 21. Americas Preclinical Oncology CRO Value Market Share by Country in 2024
Figure 22. United States Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Preclinical Oncology CRO Market Size Market Share by Region in 2024
Figure 27. APAC Preclinical Oncology CRO Market Size Market Share by Type (2020-2025)
Figure 28. APAC Preclinical Oncology CRO Market Size Market Share by Application (2020-2025)
Figure 29. China Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 33. India Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Preclinical Oncology CRO Market Size Market Share by Country in 2024
Figure 36. Europe Preclinical Oncology CRO Market Size Market Share by Type (2020-2025)
Figure 37. Europe Preclinical Oncology CRO Market Size Market Share by Application (2020-2025)
Figure 38. Germany Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 39. France Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Preclinical Oncology CRO Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Preclinical Oncology CRO Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 52. APAC Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 53. Europe Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 55. United States Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 56. Canada Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 57. Mexico Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 58. Brazil Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 59. China Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 60. Japan Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 61. Korea Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 63. India Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 64. Australia Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 65. Germany Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 66. France Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 67. UK Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 68. Italy Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 69. Russia Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 70. Egypt Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 71. South Africa Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 72. Israel Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 73. Turkey Preclinical Oncology CRO Market Size 2026-2031 ($ millions)
Figure 74. Global Preclinical Oncology CRO Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Preclinical Oncology CRO Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Preclinical Oncology CRO Market Size 2026-2031 ($ millions)